NCLT shareholders approve Dr Agarwal's Eye Hospital amalgamation scheme
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NCLT convened meeting on July 2, 2026, where equity shareholders of Dr Agarwal's Eye Hospital approved the Scheme of Amalgamation with Dr Agarwal's Health Care Limited. Of about 44.49 lakh votes cast, 89.86 percent (around 39.98 lakh) voted in favor and 10.14 percent (around 4.51 lakh) voted against. Promoters voted nearly 100 percent in favor. The scheme still needs NCLT sanction and other regulatory clearances before becoming effective.
Amalgamation clears shareholder hurdle; needs NCLT sanction and other approvals before taking effect, streamlining the group structure.